← Evidence map

ReviewGenes & cancer2018

The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy.

Long Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

233 papers cite itlatest 60 shown

2018
…
2021
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30603054